G. Tumor senescence and radioresistant tumor-initiating cells (TICs): let sleeping dogs lie! Breast Cancer Res. 12, 111 (2010). Article PubMed PubMed Central CAS Google Scholar Dong, Q. et al. Radioprotective effects of BMI-1 involve epigenetic silencing of oxidase genes and enhanced DNA ...
Biomarkers that are redox-related or immune-related might help evaluate the status of patients with cancer and provide insight into how best to combine radiotherapy with biological treatments in each individualAbstract The past 20 years have seen dramatic changes in the delivery of radiation therapy,...
Disclosed herein are methods of treatment by administering SRA737 as a monotherapy or in a combination therapy that is useful for treating patients with cancer.Inventors: Hassig, Christian Andrew (San Diego, CA, US) Milutinovic, Snezana (San Diego, CA, US) Hansen, Ryan James (San Diego...
2. The method of claim 1, wherein the cancer is selected from the group consisting of melanoma, lymphoma, esophageal cancer, liver cancer, head and neck cancer, bladder cancer, endometrial cancer, kidney cancer, thyroid cancer, breast cancer, colorectal cancer, leukemia, lung cancer, pancreatic...
colorectal cancer, non-small cell lung cancer, Human Papilloma Virus-associated cervical, oropharyngeal, penis, ovarian cancer, anal, thyroid or vaginal cancer or Epstein-Barr Virus-associated nasopharyngeal carcinoma, gastric cancer, rectal cancer, thyroid cancer, Hodgkin lymphoma or diffuse large B-ce...
(gastric) cancer, supratentorial primitive neuroectodermal tumors, testicular cancer, throat cancer, thymoma, thymoma and thymic carcinoma, thyroid cancer, transitional cell cancer of the renal pelvis and ureter and other urinary organs, gestational trophoblastic tumor, urethral cancer, endometrial uterine ...
3. A method of treating cancer in an individual wherein cancer treatment comprises first administering to the individual an effective amount of a B-RAF inhibitor and second administering to the individual an effective amount of the B-RAF inhibitor and an effective amount of immune checkpoint inhibi...
In some aspects, provided herein are methods of treating a cancer comprising administering to a subject in need thereof an effective amount of a compound of Formula (I): or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, Ra, and Rb are as described herein. In some em...
The invention relates to methods for treating a subject by manipulating HER-2 on a cell as well as related products. The methods include methods of treating cancer using fatty acid
The method of the present invention may be used with any animal, such as a mammal or a bird (avian), more preferably a mammal. Poultry are a preferred bird. Exemplary mammals include, but are not limited to rats, mice, cats, dogs, horses, cows, sheep, pigs, and more preferably ...